Hosted on MSN

Revvity advances AI-driven scientific discovery with Signals Xynthetica

Revvity, Inc. RVTY recently introduced Signals Xynthetica, a next-generation AI-augmented design platform aimed at transforming molecular and materials discovery across scientific industries.
Business Wire

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making ...
Morningstar

Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery

New AI Models-as-a-Service offering to integrate in-silico design with experimental data to continuously improve predictive power and accelerate scientific innovation Across life sciences and ...
News Medical

Revvity ignites scientific breakthroughs at SLAS2025

Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI ™ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity’s Harmony ™ and ...
Seeking Alpha

Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities

Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions ACD/Labs brings deep expertise in supporting ...
Seeking Alpha

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering Lilly TuneLab was established to make advanced AI/ML models, trained on ...